In addition, immunostimulatory molecules such as anti-inflammatory cytokines and indoleamine 2,3-dioxygenase (IDO) are released from the tumor with the activation of non-canonical NF-κB signaling, allowing the formation of an immunosuppressive microenvironment (19). The gene discussed is NFKB1; the disease is neoplasm.